{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:49:12Z","timestamp":1787003352134,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,7,7]],"date-time":"2017-07-07T00:00:00Z","timestamp":1499385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,7,7]],"date-time":"2017-07-07T00:00:00Z","timestamp":1499385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The chloride\/phosphate ratio (Cl\/PO4) has been suggested to have a role in primary hyperparathyroidism (PHPT), but the associations between Cl\/PO4 combined with ALP level and PHPT has not been well-studied. Our aim was to investigate the predictive value of combination Cl\/PO4 with ALP for PHPT. A cross-sectional retrospective analysis was conducted to examine 172 patients diagnosed with PHPT categorized into two groups: normocalcaemic primary hyperparathyroidism (NPHPT) group and hypercalcaemia PHPT group. We found that Cl\/PO4 levels and ALP levels in the NPHPT and hypercalcaemia PHPT group were both significantly higher than normal controls. Cl\/PO4 and ALP levels were an independent risk factor for PHPT. Cl\/PO4 combined with ALP increased the receiver-operating characteristic curves (ROC-AUC) and the diagnostic value in NPHPT and hypercalcaemia PHPT group (0.913; 95% CI, 0.744\u20131.000 and 0.932; 95% CI, 0.897\u20130.966, respectively), specificity of 92.8% and sensitivity of 98%. In conclusion, combination Cl\/PO4 with ALP might be a low-cost, simple, available predictive marker of PHPT in Chinese individuals, particularly Chinese remote region where the method used to measure PTH cannot be done. Moreover, due to serum calcium level in NPHPT, Cl\/PO4 combined with ALP level measurement have great potential to predict significant occurrence of NPHPT.<\/jats:p>","DOI":"10.1038\/s41598-017-05183-6","type":"journal-article","created":{"date-parts":[[2017,7,3]],"date-time":"2017-07-03T07:03:10Z","timestamp":1499065390000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The chloride\/phosphate ratio combined with alkaline phosphatase as a valuable predictive marker for primary hyperparathyroidism in Chinese individuals"],"prefix":"10.1038","volume":"7","author":[{"given":"Qianqian","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianxi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfeng","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqian","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,7]]},"reference":[{"key":"5183_CR1","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/0002-9343(69)90222-8","volume":"47","author":"MR Wills","year":"1967","unstructured":"Wills, M. R. et al. Normocalcemic Primary hyperparathyroidism. am J Med \n                           47, 384\u2013391 (1967).","journal-title":"am J Med"},{"key":"5183_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jocd.2012.12.001","volume":"16","author":"NE Cusano","year":"2013","unstructured":"Cusano, N. E., Silverberg, S. J. & Bilezikian, J. P. Normocalcemic primary hyperparathyroidism. J Clin Densitom \n                           16, 33\u201339 (2013).","journal-title":"J Clin Densitom"},{"key":"5183_CR3","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.nurpra.2015.12.017","volume":"12","author":"RP Velez","year":"2016","unstructured":"Velez, R. P., Donnelly-Strozzo, M. & Stanik-Hutt, J. Simplifying the Complexity of Primary Hyperparathyroidism. The Journal for Nurse Practitioners \n                           12, 346\u2013352 (2016).","journal-title":"The Journal for Nurse Practitioners"},{"key":"5183_CR4","doi-asserted-by":"publisher","first-page":"4641","DOI":"10.1210\/jc.2002-021404","volume":"88","author":"GH Maruani","year":"2003","unstructured":"Maruani, G. H. et al. Normocalcemic primary hyperparathyroidism: evidence for a generalized target-tissue resistance to parathyroid hormone. J Clin Endocrinol Metab \n                           88, 4641\u20134648 (2003).","journal-title":"J Clin Endocrinol Metab"},{"key":"5183_CR5","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1136\/gut.39.2.273","volume":"39","author":"G Cadiot","year":"1996","unstructured":"Cadiot, G. et al. Oral calcium tolerance test in the early diagnosis. Gut \n                           39, 273\u2013278 (1996).","journal-title":"Gut"},{"key":"5183_CR6","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/0002-9610(75)90365-7","volume":"130","author":"CD Reeves","year":"1975","unstructured":"Reeves, C. D. et al. Differential diagnosis of hypercalcemia by the chloride phosphate ratio. The American Journal of Surgery \n                           130, 166\u2013171 (1975).","journal-title":"The American Journal of Surgery"},{"key":"5183_CR7","first-page":"75","volume":"247","author":"ET Wong","year":"1982","unstructured":"Wong, E. T. & Freier, E. F. The differential diagnosis of hypercalcemia. An algorithm for more effective use of laboratory tests. JAMA \n                           247, 75\u201380 (1982).","journal-title":"An algorithm for more effective use of laboratory tests. JAMA"},{"key":"5183_CR8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/000313480407000105","volume":"70","author":"JC Boughey","year":"2004","unstructured":"Boughey, J. C. et al. Chloride phosphate ratio in primary hyperparathyroidism. The American Surgeon \n                           70, 25\u201328 (2004).","journal-title":"The American Surgeon"},{"key":"5183_CR9","unstructured":"McComb, R. M. Bowers, G. N. Posen, S. Alkaline Phosphatase. Springer, 25 (2011)."},{"key":"5183_CR10","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1055\/s-0028-1092784","volume":"11","author":"PD Broulik","year":"1979","unstructured":"Broulik, P. D. & Pacovsky, V. The chloride phosphate ratio as the screening test for primary hyperparathyroidism. Horm Metab Res \n                           11, 577\u2013579 (1979).","journal-title":"Horm Metab Res"},{"key":"5183_CR11","first-page":"801","volume":"34","author":"AA Mismar","year":"2013","unstructured":"Mismar, A. A. et al. Performance of chloride phosphate test in patients with primary hyperparathyroidism. Is it related to calcium level. Saudi Med J \n                           34, 801\u2013805 (2013).","journal-title":"Is it related to calcium level. Saudi Med J"},{"key":"5183_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/628368","volume":"2015","author":"K \u0160tefkov\u00e1","year":"2015","unstructured":"\u0160tefkov\u00e1, K., Proch\u00e1zkov\u00e1, J. & Pachern\u00edk, J. Alkaline Phosphatase in. Stem Cells. Stem Cells International \n                           2015, 1\u201311 (2015).","journal-title":"Stem Cells. Stem Cells International"},{"key":"5183_CR13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0009-8981(83)90404-7","volume":"133","author":"JJ Stepan","year":"1983","unstructured":"Stepan, J. J. et al. Relationship phosphatase of plasma tartrate resistant acid to the bone isoenzyme of serum alkaline phosphatase in hyperparathyroidism. Clinica Chimica Acra \n                           133, 189\u2013200 (1983).","journal-title":"Clinica Chimica Acra"},{"key":"5183_CR14","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1365-2265.2010.03958.x","volume":"75","author":"Y Ning","year":"2011","unstructured":"Ning, Y., Donnan, P. T. & Leese, G. P. A record linkage study of outcomes in patients with mild primary hyperparathyroidism: The Parathyroid Epidemiology and Audit Research Study (PEARS). Clinical Endocrinology (Oxf) \n                           75, 169\u2013176 (2011).","journal-title":"Clinical Endocrinology (Oxf)"},{"key":"5183_CR15","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1210\/jc.2012-4022","volume":"98","author":"MW Yeh","year":"2013","unstructured":"Yeh, M. W. et al. Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J Clin Endocrinol Metab \n                           98, 1122\u20131129 (2013).","journal-title":"J Clin Endocrinol Metab"},{"key":"5183_CR16","first-page":"265","volume":"59","author":"L Qing","year":"2015","unstructured":"Qing, L. et al. The key role of 99mTc-MIBI SPECT\/CT in the diagnosis of parathyroid adenoma: a case report. Arch. Endocrinol Metab \n                           59, 265\u2013269 (2015).","journal-title":"Endocrinol Metab"},{"key":"5183_CR17","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0140-6736(09)60507-9","volume":"374","author":"WD Fraser","year":"2009","unstructured":"Fraser, W. D. Hyperparathyroidism. Lancet \n                           374, 145\u2013158 (2009).","journal-title":"Lancet"},{"key":"5183_CR18","doi-asserted-by":"crossref","unstructured":"James, H., Thompson, G. B., Wermers, R. A. Primary Hyperparathyroidism in Pregnancy [M]\/\/Hyperparathyroidism. Springer International Publishing 129\u2013135 (2016).","DOI":"10.1007\/978-3-319-25880-5_15"},{"key":"5183_CR19","doi-asserted-by":"crossref","unstructured":"Bilezikian, J. P. Primary Hyperparathyroidism. Endotext, 2000.","DOI":"10.1016\/B978-0-12-412650-3.50035-1"},{"key":"5183_CR20","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/S0140-6736(80)91783-3","volume":"315","author":"R Gregory","year":"1980","unstructured":"Gregory, R., Mundy, D. C. & Fisken, R. Primary hyperparathyroidism: changes in the pattern of clinical presentation. Lancet \n                           315, 1317\u20131320 (1980).","journal-title":"Lancet"},{"key":"5183_CR21","doi-asserted-by":"publisher","first-page":"5353","DOI":"10.1210\/jc.2002-021370","volume":"87","author":"JP Bilezikian","year":"2002","unstructured":"Bilezikian, J. P. et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab \n                           87, 5353\u20135361 (2002).","journal-title":"J Clin Endocrinol Metab"},{"key":"5183_CR22","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/cen.12569","volume":"82","author":"C Berger","year":"2014","unstructured":"Berger, C. et al. Characteristics of hyperparathyroid states in the Canadian multicentre osteoporosis study (CaMos) and relationship to skeletal markers. Clin Endocrinol (Oxf) \n                           82, 359\u2013368 (2014).","journal-title":"Clin Endocrinol (Oxf)"},{"key":"5183_CR23","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1097\/00029330-201409200-00013","volume":"127","author":"L Sun","year":"2014","unstructured":"Sun, L. et al. Preoperative serum alkaline phosphatase: a predictive factor for early hypocalcaemia following parathyroidectomy of primary hyperparathyroidism. Chin Med J (Engl) \n                           127, 3259\u20133264 (2014).","journal-title":"Chin Med J (Engl)"},{"key":"5183_CR24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.7326\/0003-4819-92-1-65","volume":"92","author":"I Fogelman","year":"1980","unstructured":"Fogelman, I. et al. Estimation of skeletal involvement in primary hyperparathyroidism. Use of 24-hour whole-body retention of technetium-99m diphosphonate. Ann Intern Med \n                           92, 65\u201367 (1980).","journal-title":"Ann Intern Med"},{"key":"5183_CR25","first-page":"1","volume":"3","author":"AM Nasir","year":"2015","unstructured":"Nasir, A. M. et al. Alkaline Phosphatase (ALP) Activity as a marker for Vitamin D deficiency. American Journal of Research Communication \n                           3, 1\u20139 (2015).","journal-title":"American Journal of Research Communication"},{"key":"5183_CR26","first-page":"249","volume":"135","author":"JB Puschett","year":"1978","unstructured":"Puschett, J. B. Renal tubular effects of parathyroid hormone an update. Clin Orhop \n                           135, 249\u2013259 (1978).","journal-title":"Clin Orhop"},{"key":"5183_CR27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.bone.2013.03.009","volume":"55","author":"TD Vu","year":"2013","unstructured":"Vu, T. D. et al. New insights into the effects of primary hyperparathyroidism on the cortical and trabecular compartments of bone. Bone \n                           55, 57\u201363 (2013).","journal-title":"Bone"},{"key":"5183_CR28","first-page":"690","volume":"14","author":"DW Dempster","year":"1993","unstructured":"Dempster, D. W. et al. Anabolic actions of parathyroid hormone on bone. Endocrine reviews \n                           14, 690\u2013709 (1993).","journal-title":"Endocrine reviews"},{"key":"5183_CR29","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.bone.2012.09.016","volume":"54","author":"T Bellido","year":"2013","unstructured":"Bellido, T., Saini, V. & Pajevic, P. D. Effects of PTH on osteocyte function. Bone \n                           54, 250\u2013257 (2013).","journal-title":"Bone"},{"key":"5183_CR30","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/jbmr.1791","volume":"28","author":"J Park\u2010Sigal","year":"2013","unstructured":"Park\u2010Sigal, J. et al. Severe hypercalcemic hyperparathyroidism developing in a patient with hyperaldosteronism and renal resistance to parathyroid hormone. Journal of Bone and Mineral Research \n                           28, 700\u2013708 (2013).","journal-title":"Journal of Bone and Mineral Research"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-05183-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-05183-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-05183-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T01:24:17Z","timestamp":1671758657000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-05183-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,7]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["5183"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-05183-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,7]]},"assertion":[{"value":"26 August 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"4868"}}